Vaut-il la peine de vacciner contre SARS-CoV-2 les patients ayant reçu des thérapies anti-CD20 ? Oui, mais à certaines conditions. | Rev Med Suisse;18(773): 499, 2022 03 16. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Vaut-il la peine de vacciner contre SARS-CoV-2 les patients ayant reçu des thérapies anti-CD20 ? Oui, mais à certaines conditions.

Bart, Pierre Alexandre.

Bart PA; Avec la collaboration du groupe MIAjour, Service de médecine interne, Centre hospitalier universitaire vaudois, Lausanne.

Rev Med Suisse ; 18(773): 499, 2022 03 16.

Article in French | MEDLINE | ID: covidwho-1754351

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral; Humans

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: French Journal: Rev Med Suisse Journal subject: Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: French Journal: Rev Med Suisse Journal subject: Medicine Year: 2022 Document Type: Article